Better Pharma Processes LogoBetter Pharma Processes for Small Molecule Drugs
target compounds
Better Pharma Processes provides process chemistry consulting and training

Training: Short Courses

Courses can be designed for a single day or multiple days.

Course price is typically based on the number of participants and the format for course materials provided (hard copies of the slides, electronic copies of the slides, and/or a textbook). The per-participant price for large audience (25 – 100) courses is negotiable.     

Courses Previously Taught:

  • General Chemistry I
  • Organic Chemistry I
  • Organic Chemistry II
  • Organic Synthetic Methods
  • Transition Metal Methods in Organic Synthesis
  • Spectroscopic Methods for the Identification of Organic Compounds
  • Pharmaceutical Process Chemistry I
    • Based on material from:
      Pharmaceutical Process Chemistry for Synthesis: Rethinking the Routes to Scale-Up

Courses under Development:

  • Heterocyclic Chemistry
  • Pharmaceutical Process Chemistry II
    • Based on material from:
      See the list of reviews currently under development.
  • Pharmaceutical Process Chemistry: Special Topics (with enough lead time)
    • A course based on material and topics of current interest to your organization.

© 2010 better pharma processes; all rights reserved


Better Pharma Processes, owned by Peter Harrington, PhD, provides consulting and training in the field of pharmaceutical process chemistry. 
Dr. Harrington's newest book, "Pharmaceutical Process Chemistry for Synthesis: Rethinking the Routes to Scale-Up", describes the process chemistry involved in several popular small-molecule drugs, including abilify®, celebrex®, crestor®, cymbalta®, flonase®, levaquin®, topamax®, valtrex®, and zyprexa®.